1. Home
  2. KALV vs GNTY Comparison

KALV vs GNTY Comparison

Compare KALV & GNTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALV
  • GNTY
  • Stock Information
  • Founded
  • KALV N/A
  • GNTY 1913
  • Country
  • KALV United States
  • GNTY United States
  • Employees
  • KALV N/A
  • GNTY N/A
  • Industry
  • KALV Biotechnology: Pharmaceutical Preparations
  • GNTY Major Banks
  • Sector
  • KALV Health Care
  • GNTY Finance
  • Exchange
  • KALV Nasdaq
  • GNTY Nasdaq
  • Market Cap
  • KALV 418.1M
  • GNTY 407.7M
  • IPO Year
  • KALV N/A
  • GNTY 2017
  • Fundamental
  • Price
  • KALV $8.36
  • GNTY $34.57
  • Analyst Decision
  • KALV Strong Buy
  • GNTY Hold
  • Analyst Count
  • KALV 6
  • GNTY 3
  • Target Price
  • KALV $26.25
  • GNTY $36.67
  • AVG Volume (30 Days)
  • KALV 421.6K
  • GNTY 34.6K
  • Earning Date
  • KALV 12-31-2024
  • GNTY 01-14-2025
  • Dividend Yield
  • KALV N/A
  • GNTY 2.77%
  • EPS Growth
  • KALV N/A
  • GNTY N/A
  • EPS
  • KALV N/A
  • GNTY 2.38
  • Revenue
  • KALV N/A
  • GNTY $117,228,000.00
  • Revenue This Year
  • KALV N/A
  • GNTY N/A
  • Revenue Next Year
  • KALV N/A
  • GNTY $4.53
  • P/E Ratio
  • KALV N/A
  • GNTY $14.59
  • Revenue Growth
  • KALV N/A
  • GNTY N/A
  • 52 Week Low
  • KALV $7.98
  • GNTY $27.01
  • 52 Week High
  • KALV $16.88
  • GNTY $38.93
  • Technical
  • Relative Strength Index (RSI)
  • KALV 36.75
  • GNTY 40.88
  • Support Level
  • KALV $8.48
  • GNTY $33.35
  • Resistance Level
  • KALV $9.30
  • GNTY $36.85
  • Average True Range (ATR)
  • KALV 0.65
  • GNTY 1.03
  • MACD
  • KALV -0.06
  • GNTY -0.43
  • Stochastic Oscillator
  • KALV 17.12
  • GNTY 28.71

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.

About GNTY Guaranty Bancshares Inc.

Guaranty Bancshares Inc is a bank holding company conducting banking activities through its wholly-owned subsidiary. The company provides its customers with a full array of relationship-driven commercial and consumer banking products and services, as well as mortgage, trust, and wealth management products and services that are tailored to meet the needs of small and medium-sized businesses, professionals, and individuals. It also provides other services such as Credit cards, Personal Loans, Business Checking, Treasury Management, and other related services. The company generates its revenue from interest on loans and investments, customer service and loan fees, fees related to the sale of mortgage loans, and trust and wealth management services.

Share on Social Networks: